Insmed Incorporated (INSM)

Nasdaq · Healthcare · Biotechnology
$141.33-2.17%As of 2026-11-22 · USD
Last session low $140.99Last session high $150.00
52-week low $90.3952-week high $212.75
Market cap
$31.01B
Sector
Healthcare

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)78.4In the overbought range (above 70)
MACD (12, 26, 9)7.87Above its signal line (4.36); histogram 3.51
Bollinger %B (20, 2)99%Inside the bands (88.76 to 142.04)
SMA 20115.40Price is 22.5% above
SMA 50111.21Price is 27.1% above
SMA 200122.59Price is 15.3% above
ATR (20)4.35% of priceAverage true range per day
52-week position42%In the middle of the 90.39 to 212.75 range

About Insmed Incorporated

Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Insider filings, 90 daysNo purchases and 2 sales (about $17.8M).
Latest fiscal yearEnded 2025-12-31: revenue of $606.42M and an operating margin of -164.0%.

More in Biotechnology